The clinical research of adenoid hypertrophy evaluation and grading system in children

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300068424

Enrollment

Unknown

Registered

2023-02-17

Start date

2023-02-20

Completion date

Unknown

Last updated

2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenoid hypertrophy in children

Interventions

Adenoid hypertrophy with or without ear complication:No

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 0 to 18 years; 2. Clinical symptoms of adenoid hypertrophy (including symptoms of obstructive sleep apnea and secretory otitis media); 3. No contraindications for adenoid surgery and secretory otitis media surgery; 4. No contraindications for soft electronic rhinoscopy.

Exclusion criteria

Exclusion criteria: 1. With adenoidectomy or tonsillectomy history; 2. Requiring direct surgical treatment without follow-up treatment; 3. Contraindications for adenoid surgery and secretory otitis media surgery; 4. Contraindications for soft electronic rhinoscopy; 5. With other systemic diseases; 6. Abnormal maxillofacial structure; 7. Unable to obtain informed consent.

Design outcomes

Primary

Measure	Time frame
Three grading scores of endoscopic adenoids;Number of cases requiring surgical intervention;Number of cases of secretory otitis media;	—

Countries

China

Contacts

Public ContactXu Hongming

Shanghai Children's Hospital

xuhongming@188.com+86 13917086351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026